An exploration of how AI and machine learning are transforming peptide research — from AlphaFold protein structure prediction to RFdiffusion generative design and QSAR modeling, plus limitations researchers must understand.
Category Archives: Peptides
A detailed scientific comparison of GHRP-2 and GHRP-6, two ghrelin-receptor-targeting GH secretagogues. Covers GHS-R1a pharmacology, selectivity differences, hunger pathway involvement, and GHRH synergy.
A scientific exploration of oral peptide delivery challenges — enzymatic degradation, mucosal permeation barriers, and cutting-edge delivery strategies including nanoparticles, SNAC permeation enhancers, and structural modifications.
A scientific examination of clenbuterol as a research compound — covering β2-AR pharmacology, thermogenic cAMP/PKA/HSL cascade, skeletal muscle anabolic signaling in animal models, and cardiac hypertrophy research.
A comprehensive research overview of epitalon (Ala-Glu-Asp-Gly), a synthetic tetrapeptide studied for telomerase activation, pineal-hypothalamic axis modulation, and aging biomarker research.
A deep-dive into retatrutide (LY3437943), the triple agonist targeting GLP-1R, GIPR, and GCGR. Covers the glucagon receptor paradox, Phase II efficacy data (~24% body weight reduction), and pharmacodynamics.
A detailed scientific comparison of GW501516 (Cardarine) and GW0742, two PPARδ agonists used in metabolic research. Covers receptor biology, fatty acid oxidation pathways, and AMPK-PPARδ crosstalk.
A comprehensive research overview of LGD-4033, a non-steroidal SARM with high AR affinity. Covers tissue-selective coactivator recruitment, preclinical selectivity data, and Phase I pharmacokinetics.
A scientific examination of tadalafil as a research compound — covering PDE5 inhibition biochemistry, cGMP/NO signaling cascade, tissue expression profiles, and emerging research in pulmonary hypertension models.
A comprehensive overview of antimicrobial peptides as a research class — covering membrane disruption mechanisms, biofilm research, LL-37 immunomodulation, and 2026 synthetic AMP design trends.










